At AstraGenomics, we envision a world where genome editing technologies can improve human health and quality of life by treating incurable diseases, providing healthy food, engineering valuable microbes, and making the most efficient usage of resources on our planet.

human health and quality of life by treating incurable diseases, providing healthy food, engineering valuable microbes, and making the most efficient usage of resources on our planet. We believe that genome editing technologies and tools can be largely expanded to possess diversified capabilities beyond current ones. A variety of unique tool systems may offer optimum solutions to fit different scenarios with best performance.

AstraGenomics was founded by scientific and industrial experts in the field of genetic engineering and data science. The company has established a systematic and continuously improving platform by integrating computational biology and lab automation. Enabled by this high-throughput approach, we have yielded a plentiful toolbox with tool systems for large fragment gene writing and nuclease-based editing. Our platform and toolbox empower us to participate in the fields of genetic medicine, molecular breeding, and industrial microbe, as well as to innovate these areas with revolutionary genome editing solutions.